Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000063 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 15, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
21,947
Total Value
$601,846.92
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 37,165 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 40,665 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 15, 2026 | Sale | 1,636 | $68.38 | $111,876.06 | 39,029 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 15, 2026 | Sale | 5,064 | $69.42 | $351,547.44 | 33,965 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 15, 2026 | Sale | 300 | $70.62 | $21,186.99 | 33,665 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 15, 2026 | Sale | 947 | $69.69 | $65,996.43 | 32,718 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Jun 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 204,063 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Jun 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 175,492 | Direct | โ | View Details |